Actively Recruiting
Surveillance of AMR in DRC
Led by University of Oxford · Updated on 2025-02-20
210
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
Sponsors
U
University of Oxford
Lead Sponsor
U
University of Kinshasa
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study addresses knowledge gaps regarding antimicrobial resistance (AMR) in sub-Saharan Africa, focusing on evaluating the feasibility of AMR surveillance and enhancing local research capacity. Conducted at a general referral hospital in semirural Kinshasa, DRC, the study will investigate bacterial infections, their resistance profiles, and related risk factors, including co-infections such as malaria.
CONDITIONS
Official Title
Surveillance of AMR in DRC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than six months
- Patients with clinically suspected bloodstream infection at hospital admission
- Patients hospitalized for less than 48 hours
- Patients or their caregivers/legal guardians must provide written consent to participate
You will not qualify if you...
- Patients with a significant history of healthcare exposure
- Patients with contraindications for phlebotomy as determined by clinician judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kinshasa, Democratic Republic of Congo, Kinshasa School of Public Health
Kinshasa, Democratic Republic of the Congo, BP 11850
Actively Recruiting
Research Team
C
Caterina Fanello, Dr.
CONTACT
M
Marie Onyamboko, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here